
    
      -  Because no one knows which of the study options is best, participants will be
           "randomized" into one of the two possible groups for GVHD prophylaxis: 1) a
           sirolimus-containing regimen (tacrolimus, sirolimus and methotrexate) or 2) a
           sirolimus-free regimen (tacrolimus and methotrexate or cyclosporine and mycophenolate
           mofetil).

        -  Participants will receive a reduced intensity conditioning regimen. This is done to
           prepare the body for transplantation. This will consist of a combination of drugs
           (either fludarabine and busulfan or fludarabine, cyclophosphamide and low-dose total
           body irradiation). The purpose of these drugs is to weaken the immune system and lower
           the chance of the body rejecting the donated stem cells.

        -  Participants will also receive the GVHD prophylaxis regimen that they have been
           randomized to. These drugs will lower the chance of rejecting the donor cells and lower
           the chance of developing GVHD.
    
  